comparemela.com

நைட் முதுமறதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers identify potential new treatment targets for Alzheimer s disease

Researchers identify potential new treatment targets for Alzheimer s disease A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer s disease, as well as existing drugs that have therapeutic potential against these targets. The potential targets are defective proteins that lead to the buildup of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer s. The 15 existing drugs identified by the researchers have been approved by the Food and Drug Administration (FDA) for other purposes, providing the possibility of clinical trials that could begin sooner than is typical, according to the researchers.

New Alzheimer s treatment targets identified – Washington University School of Medicine in St Louis

Cruchaga lab A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs with therapeutic potential. The targets are defective proteins, and the 15 existing drugs identified by the researchers have been approved by the Food and Drug Administration (FDA) for other purposes, providing the possibility of clinical trials that could begin sooner than is typical, according to the researchers. A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.

Study identifies potential new treatment targets for Alzheimer s disease

Study identifies potential new treatment targets for Alzheimer s disease ANI | Updated: Jul 09, 2021 08:56 IST Washington [US], July 9 (ANI): Potential new treatment targets for Alzheimer s disease, as well as existing drugs that have therapeutic potential against these targets, have been identified by a research team at Washington University School of Medicine in St Louis. The new study, funded by the National Institute on Aging of the National Institutes of Health (NIH), was published in the journal Nature Neuroscience. The potential targets are defective proteins that lead to the build-up of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer s.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.